Fig. 3From: Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trialEffect of Canagliflozin on renal fat fraction (FF) in newly diagnosed T2DM patients. A Kidney Dixion MRI images of two groups of newly diagnosed patients before and after treatment B Changes of renal FF in two groups before and after intervention C Analysis of correlation between baseline BMI and renal FF. * P < 0.05,** P < 0.01Back to article page